TaiDic accomplish cutting-edge test strip by the utilization of FAD-dependent glucose dehydrogenase (GDH-FAD) enzyme for blood glucose measurement. Compared with glucose oxidase (GOD), GDH-FAD could avoid interference from blood oxygen variation. Because of this advantage, GDH-FAD strip could be applied on most of blood sample from capillary, artery, vein and AST.

Meanwhile, TaiDoc GDH-FAD strip could prevent from maltose and galactose interference in blood samples. By contrast, pyrroloquinoline quinone glucose dehydrogenase (GDH-PQQ) could give inaccurate glucose reading with patients undergoing intravenous drip solutions containing maltose. TaiDoc GDH -FAD strip could be one of the best solutions in self- diagnostic blood glucose management.

Blood Sample Type
	Artery	Vein	Capillary	AST	Dialysis Patient with Maltose
TaiDoc GDH-FAD
GDH-PQQ**
GOD

* TaiDoc does not produce or use GDH-PQQ glucose test strips in health devices.  
** Please refer to the FDA Notification for potentially fatal errors with GDH-PQQ Glucose Monitoring Technology. 

Our outstanding in-house biochemistry R&D team develops the most reliable biosensors with productive consistency and stability. By utilizing the real-time online monitoring system to actively manage each production step and assure the quality strip by strip.

• Innovative Multiple Layer Structure comprises several physical and chemical patented designs to efficiently reduce the interference of electrochemical signal transmission and make sure the blood sample can be easily and correctly obtained by users.
• Smart Short Circuit Design for manufacturers’ or consumers’ identification and differentiation.
• Glucose Oxidase (GOD) and Glucose Dehydrogenase (GDH) enzymes are both ready for flexibly market segmentation.
• Alternative Site Testing (AST) function is available. The AST function can provide users to test the blood glucose at the side other than fingertips. That can benefit the users to avoid the repeated trauma in fingertips and reduce pain